#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Alagille syndrome Heart disease congenital Cataract Kearns-Sayre syndrome Cutaneous T-cell lymphoma stage II Hypereosinophilic syndrome Frontotemporal dementia Orthostatic hypotension Chronic cutaneous lupus erythematosus Acute graft versus host disease in liver Hereditary haemorrhagic telangiectasia Encephalopathy neonatal Dedifferentiated liposarcoma Osteosarcoma metastatic Metastases to central nervous system More trials…

    Learn about Rare Diseases

    Marfan’s syndrome – Trials in Disease Myxofibrosarcoma – Trials in Disease Burkitt’s lymphoma – Trials in Disease Focal segmental glomerulosclerosis – Life with Disease Hypereosinophilic syndrome Ewing’s sarcoma metastatic – Treatment Nephroblastoma – Trials in Disease Mantle cell lymphoma stage III – Diagnostics Angiosarcoma recurrent – Basic Information Primary mediastinal large B-cell lymphoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Lurbinectedin Fenoterol Hydrobromide Cefazolin Resiquimod Sulfate Magnesium Oxybate Sapablursen BUDOPRUTUG Technetium (99Mtc) Eplerenone Ascorbic Acid Bp Tislelizumab Ethambutol Histamine Hydrochloride Roginolisib Esketamine Vinflunine Anhydrous Cidofovir ASP2957 LTX-002 SODIUM Oxazepam More therapies…

    Learn about Your Condition

    Burning mouth syndrome Myocarditis post infection Toxicity to various agents Vulvovaginal candidiasis Triple negative breast cancer Desmoid tumour Narcolepsy Endometrial cancer recurrent Pseudoxanthoma elasticum Cardiac failure acute Dent's disease Rectal neoplasm Hepatotoxicity Primary biliary cholangitis Papulopustular rosacea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • Study of Incobotulinumtoxin-A Injections for Diabetic Neuropathic Pain in the Lower Limbs

    Recruiting

    2 1 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
    Denmark

  • Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease and Fibrosis

    Recruiting

    3 1 1
    Investigated Drugs:
    • Fazirsiran
    • Saline
    Austria Belgium Czechia Denmark France Germany +7

  • Study of Semaglutide for Treating Prediabetes in Women with Previous Gestational Diabetes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Glucose tolerance impaired
    Investigated Drugs:
    • Semaglutide
    Belgium

  • Study on the Required Dose of Cholecalciferol for Managing Vitamin D Deficiency in Postmenopausal Women

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Menopausal symptoms
    • Vitamin D deficiency
    Investigated Drugs:
    • Colecalciferol
    Spain

  • Study on Long-Term Safety of Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency-Related Liver Disease

    Recruiting

    3 1 1
    Investigated Drugs:
    • Fazirsiran
    Austria Germany Portugal

  • Study on Sodium Phenylbutyrate for Improving Blood Sugar Control in Type 2 Diabetes Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Sodium Phenylbutyrate
    The Netherlands
Previous Page
1 … 19 20 21 22 23 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!